Health and Pharma – Servitization

If we have known the case of GSK at the beginning of the day, in this last session, three cases will show how health and pharmaceutical sectors can benefit from the use of digital technologies in the management of the value chain, from the artificial intelligence recognition by artificial vision, to control of the fraudulent product. It will be a healthy way to close the second day of the Congress Industry 4.0.